AtriCure, Inc. (ATRC) Gross Margin
- Gross margin · 12 months: Value 76.30%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 76.30% | Gross profit / revenue. Period ending 2026-06-30. $434.61M ÷ $569.62M × 100 ≈ 76.30% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 434.61M USD | Gross Profit |
| Revenue | 569.62M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $434.61M | $569.62M | (m) | 76.30% |
| 2026-03-31 | $417.46M | $552.16M | (m) | 75.61% |
| 2025-12-31 | $400.78M | $534.53M | (m) | 74.98% |
| 2025-09-30 | $388.06M | $518.30M | (m) | 74.87% |
| 2025-06-30 | $373.52M | $499.95M | (m) | 74.71% |
| 2025-03-31 | $358.88M | $480.08M | (m) | 74.76% |
| 2024-12-31 | $347.52M | $465.31M | (m) | 74.69% |
| 2024-09-30 | $334.72M | $447.57M | (m) | 74.79% |
| 2024-06-30 | $321.80M | $429.95M | (m) | 74.84% |
| 2024-03-31 | $312.03M | $414.60M | (m) | 75.26% |
| 2023-12-31 | $300.37M | $399.25M | (m) | 75.23% |
| 2023-09-30 | $285.67M | $380.73M | (m) | 75.03% |
| 2023-06-30 | $273.51M | $365.69M | (m) | 74.79% |
| 2023-03-31 | $259.95M | $349.30M | (m) | 74.42% |
| 2022-12-31 | $245.94M | $330.38M | (m) | 74.44% |
| 2022-09-30 | $235.84M | $315.57M | (m) | 74.74% |
| 2022-06-30 | $226.36M | $302.78M | (m) | 74.76% |
| 2022-03-31 | $216.91M | $289.63M | (m) | 74.89% |
| 2021-12-31 | $205.86M | $274.33M | (m) | 75.04% |
| 2021-09-30 | $193.28M | $258.84M | (m) | 74.67% |
| 2021-06-30 | $181.39M | $243.13M | (m) | 74.60% |
| 2021-03-31 | $154.97M | $212.58M | (m) | 72.90% |
| 2020-12-31 | $149.31M | $206.53M | $655.00K | 72.29% |
| 2020-09-30 | $151.65M | $210.13M | (m) | 72.17% |
| 2020-06-30 | $153.11M | $211.98M | (m) | 72.23% |
| 2020-03-31 | $169.35M | $230.07M | (m) | 73.61% |
| 2019-12-31 | $170.34M | $230.81M | $635.00K | 73.80% |
| 2019-09-30 | $164.15M | $222.38M | (m) | 73.82% |
| 2019-06-30 | $158.30M | $215.71M | (m) | 73.39% |
| 2019-03-31 | $152.49M | $208.60M | (m) | 73.10% |
| 2018-12-31 | $147.12M | $201.63M | $785.00K | 72.97% |
| 2018-09-30 | $141.21M | $194.80M | (m) | 72.49% |
| 2018-06-30 | $136.18M | $187.01M | (m) | 72.82% |
| 2018-03-31 | $130.66M | $180.44M | (m) | 72.41% |
| 2017-12-31 | $126.16M | $174.72M | (m) | 72.21% |
| 2017-09-30 | $122.38M | $169.81M | (m) | 72.07% |
| 2017-06-30 | $118.93M | $166.00M | (m) | 71.64% |
| 2017-03-31 | $115.19M | $160.44M | (m) | 71.80% |
| 2016-12-31 | $111.10M | $155.11M | (m) | 71.63% |
| 2016-09-30 | $107.75M | $149.81M | (m) | 71.92% |
| 2016-06-30 | $102.75M | $142.90M | (m) | 71.91% |
| 2016-03-31 | $97.05M | $135.81M | (m) | 71.46% |
| 2015-12-31 | $92.88M | $129.75M | (m) | 71.58% |
| 2015-09-30 | $87.75M | $123.31M | (m) | 71.16% |
| 2015-06-30 | $84.16M | $118.56M | (m) | 70.99% |
| 2015-03-31 | $79.83M | $112.49M | (m) | 70.96% |
| 2014-12-31 | $75.75M | $107.45M | (m) | 70.50% |
| 2014-09-30 | $71.00M | $99.92M | (m) | 71.05% |
| 2014-06-30 | $66.79M | $93.39M | (m) | 71.52% |
| 2014-03-31 | $63.13M | $87.31M | (m) | 72.31% |
| 2013-12-31 | $59.56M | $81.89M | (m) | 72.74% |
| 2013-09-30 | $56.90M | $78.37M | (m) | 72.60% |
| 2013-06-30 | $53.76M | $74.36M | (m) | 72.29% |
| 2013-03-31 | $51.35M | $72.20M | (m) | 71.12% |
| 2012-12-31 | $50.01M | $70.25M | (m) | 71.20% |
| 2012-09-30 | $48.75M | $68.65M | (m) | 71.02% |
| 2012-06-30 | $48.29M | $67.73M | (m) | 71.30% |
| 2012-03-31 | $47.86M | $66.24M | (m) | 72.24% |
| 2011-12-31 | $47.00M | $64.40M | (m) | 72.97% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $45.39M | $59.01M | (m) | 76.92% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2009-12-31 | $41.78M | $54.53M | (m) | 76.62% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |